Tumour-Associated Trypsin Inhibitor (TATI) in Human Ovarian Cyst Fluid. Comparison With CA 125 and CEA

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1987.175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

HE4 a Novel Tumour Marker for Ovarian Cancer: Comparison With CA 125 and ROMA Algorithm in Patients With Gynaecological Diseases

Tumor Biology
MedicineCancer Research
2011English

Preoperative Differentiation Between Malignant and Benign Ovarian Masses in Patients With Normal CA-125 Levels

Gynecology Obstetrics & Reproductive Medicine
2016English

The Role of CA‐125 in the Management of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Diagnostic Performance of CA 125, HE4, and Risk of Ovarian Malignancy Algorithm for Ovarian Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Pancreatic Trypsin Inhibitor. 2. Reaction With Trypsin

Biochemical Journal
1953English

Autoimmune Haemolytic Anaemia Associated With Ovarian Dermoid Cyst

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1968English

Prognostic Value of Monitoring Tumour Markers CA 15-3 and CEA During Fulvestrant Treatment

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

Study of Human Urinary Trypsin Inhibitor

Japanese Journal of Urology
Urology
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy